Citichem India IPO

Incorporated in 1992, Citichem India Limited is engaged in buying and supplying organic and inorganic chemicals, bulk drugs, and food chemicals to the the pharmaceutical industry. The company focuses on the direct supply of specialty chemicals, bulk drugs, and intermediate products. It trades in specialty chemicals and intermediates that have a wide range of applications across industries such as aluminum, steel, textiles, paper, dairy, paints, dyes and intermediates, soap making, pharmaceuticals, food, and adhesives. The company also supplies food preservatives and chemicals under its brand name, which are then sold through its distribution team, ensuring the safe delivery of bulk supplies. The company supplies products such as Caustic Soda Flakes, Caustic Soda Lye, Citric Acid Monohydrate, Hydrogen Peroxide, and more. Business division: Specialty Chemicals, Intermediates & Active Pharmaceutical Ingredients (API): The company specializes in indenting, sourcing, make-to-order outsourcing, and supplying specialty chemicals, bulk drugs, and APIs to domestic and international clients in the pharmaceutical, paint, and food industries. Food Chemicals: The company handles the repackaging, retail distribution, and marketing of food chemicals. Laboratory Chemicals: The company offers a one-stop solution for all types of laboratory chemicals. As of June 30, 2024, The company has 9 employees. Competitive Strengths: Experienced Promoters and management team Scalable Business Model Focus on quality and innovation Location Advantage Cordial Relationships with Suppliers &Customers Dedicated after-sales network

The Company intends to utilize the Net Proceeds from the Fresh Issue towards the following objectives: For Capital expenditure for acquisition of Property For purchasing of Transportation Vehicles and accessories For General Corporate Purposes For meeting the Issue Expenses.

All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application. No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever Please read all Tearms and conditions , and agree to use the App